Pharmacokinetic/pharmacodynamic model of the testosterone effects of triptorelin administered in sustained release formulations in patients with prostate cancer
作者单位:Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Navarra[1]Drug Metabolism and Pharmacokinetics, Ipsen Pharma S.A, Barcelona, Spain[2]